BACKGROUND: Immune escape is one prerequisite for the formation of neoplasms that is reflected by the pattern of immune cell infiltration. Abundant monocytic infiltration without apparent phagocytic activity is well known in human gliomas, while other types of human intracranial tumours have not yet been investigated. MATERIALS AND METHODS: We analysed LCA-positive lymphocytes and CD68-positive macrophages/microglia by immunohistochemistry in 67 intracranial neoplasms: 18 glioblastomas (GBM), 14 primitive neuroectodermal tumours and medulloblastomas (PNET), metastases of 9 adenocarcinomas and of 8 malignant melanomas, and 18 benign meningiomas. RESULTS: Levels of monocytic infiltration in GBM and adenocarcinomas were higher than in PNET and meningiomas. Lymphocytes were rare in all tested tumours. No differences were found between all malignant neoplasms and benign meningiomas and between primary intracranial and metastatic tumours. CONCLUSION: Malignancy or primary intracranial origin seem not to be major determinants of immune cell infiltration. Different patterns of cytokine production may explain the differences in single tumour entities.
BACKGROUND: Immune escape is one prerequisite for the formation of neoplasms that is reflected by the pattern of immune cell infiltration. Abundant monocytic infiltration without apparent phagocytic activity is well known in humangliomas, while other types of humanintracranial tumours have not yet been investigated. MATERIALS AND METHODS: We analysed LCA-positive lymphocytes and CD68-positive macrophages/microglia by immunohistochemistry in 67 intracranial neoplasms: 18 glioblastomas (GBM), 14 primitive neuroectodermal tumours and medulloblastomas (PNET), metastases of 9 adenocarcinomas and of 8 malignant melanomas, and 18 benign meningiomas. RESULTS: Levels of monocytic infiltration in GBM and adenocarcinomas were higher than in PNET and meningiomas. Lymphocytes were rare in all tested tumours. No differences were found between all malignant neoplasms and benign meningiomas and between primary intracranial and metastatic tumours. CONCLUSION:Malignancy or primary intracranial origin seem not to be major determinants of immune cell infiltration. Different patterns of cytokine production may explain the differences in single tumour entities.
Authors: Steven H Shen; Karolina Woroniecka; Andrew B Barbour; Peter E Fecci; Luis Sanchez-Perez; John H Sampson Journal: Expert Opin Biol Ther Date: 2020-02-17 Impact factor: 4.388
Authors: Giulia Fulci; Laura Breymann; Davide Gianni; Kazuhiko Kurozomi; Sarah S Rhee; Jianhua Yu; Balveen Kaur; David N Louis; Ralph Weissleder; Michael A Caligiuri; E Antonio Chiocca Journal: Proc Natl Acad Sci U S A Date: 2006-08-14 Impact factor: 11.205
Authors: Chris A Learn; Peter M Grossi; Robert J Schmittling; Weihua Xie; Duane A Mitchell; Isaac Karikari; ZhengZheng Wei; Holly Dressman; John H Sampson Journal: J Neuroimmunol Date: 2006-11-29 Impact factor: 3.478
Authors: D S Markovic; K Vinnakota; S Chirasani; M Synowitz; H Raguet; K Stock; M Sliwa; S Lehmann; R Kälin; N van Rooijen; K Holmbeck; F L Heppner; J Kiwit; V Matyash; S Lehnardt; B Kaminska; R Glass; H Kettenmann Journal: Proc Natl Acad Sci U S A Date: 2009-07-15 Impact factor: 11.205
Authors: Mohamed Abou-Ghazal; David S Yang; Wei Qiao; Chantal Reina-Ortiz; Jun Wei; Ling-Yuan Kong; Gregory N Fuller; Nobuyoshi Hiraoka; Waldemar Priebe; Raymond Sawaya; Amy B Heimberger Journal: Clin Cancer Res Date: 2008-12-15 Impact factor: 12.531
Authors: Giulia Fulci; Nina Dmitrieva; Davide Gianni; Elisabeth J Fontana; Xiaogang Pan; Yanhui Lu; Claire S Kaufman; Balveen Kaur; Sean E Lawler; Robert J Lee; Clay B Marsh; Daniel J Brat; Nico van Rooijen; Anat O Stemmer-Rachamimov; Anat Stemmer Rachamimov; Fred H Hochberg; Ralph Weissleder; Robert L Martuza; E Antonio Chiocca Journal: Cancer Res Date: 2007-10-01 Impact factor: 12.701